Nicolaì Maass

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

Gϋnter von Minckwitz, Andreas du Bois, Marcus Schmidt et al. · Journal of Clinical Oncology · 2009 · 689 citations

Medicine, Oncology, Pharmacotherapy +17

Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer

Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt et al. · Journal of Medical Genetics · 2016 · 225 citations

Life Sciences, Genetics, Oncology +17

Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer

M. Bauer, Jens C. Eickhoff, Michael N. Gould et al. · Breast Cancer Research and Treatment · 2007 · 217 citations

Medicine, Cancer Biology, Oncology +10

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

Gϋnter von Minckwitz, Kathrin Schwedler, Marcus Schmidt et al. · European Journal of Cancer · 2011 · 184 citations

Medicine, Oncology, Pharmacotherapy +17

Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases

Andreas M. Stark, Kerrin Tongers, Nicolaì Maass et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 146 citations · Full text

Medicine, Molecular Biology, Oncology +14